Protocol #0113-CL-2001 entitled, "A Randomized, Double

  • Verghese, Priya, (PI)

Project: Research project

Description

Protocol #0113-CL-2001 entitled, "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney
StatusFinished
Effective start/end date4/1/1412/31/18

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Cytomegalovirus
Vaccines
Placebos
Kidney
Safety